Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
~ Supports Strategic Discussions and Global Launch Activities ~ ~ Extends Access to Additional Undrawn Capital As Needed During Global PEDMARK® Rollout ~ ~ Facilitates Market Expansion.
~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October.
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
RESEARCH TRIANGLE PARK, N.C., June 06, 2023 Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced Pedmarqsi™– known as PEDMARK® in. | June 6, 2023